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Dual-controlled optogenetic 
system for the rapid down-
regulation of protein levels in 
mammalian cells
Julia Baaske1,2, Patrick Gonschorek1,2,8, Raphael Engesser2,3, Alazne Dominguez-Monedero4,  
Katrin Raute1,2,5, Patrick Fischbach6, Konrad Müller1,9, Elise Cachat4, Wolfgang W. A. Schamel1,2,7, 
Susana Minguet  1,2,7, Jamie A. Davies4, Jens Timmer2,3, Wilfried Weber1,2 & 
Matias D. Zurbriggen6
Optogenetic switches are emerging molecular tools for studying cellular processes as they offer 
higher spatiotemporal and quantitative precision than classical, chemical-based switches. Light-
controllable gene expression systems designed to upregulate protein expression levels meanwhile 
show performances superior to their chemical-based counterparts. However, systems to reduce 
protein levels with similar efficiency are lagging behind. Here, we present a novel two-component, 
blue light-responsive optogenetic OFF switch (‘Blue-OFF’), which enables a rapid and quantitative 
down-regulation of a protein upon illumination. Blue-OFF combines the first light responsive repressor 
KRAB-EL222 with the protein degradation module B-LID (blue light-inducible degradation domain) to 
simultaneously control gene expression and protein stability with a single wavelength. Blue-OFF thus 
outperforms current optogenetic systems for controlling protein levels. The system is described by a 
mathematical model which aids in the choice of experimental conditions such as light intensity and 
illumination regime to obtain the desired outcome. This approach represents an advancement of dual-
controlled optogenetic systems in which multiple photosensory modules operate synergistically. As 
exemplified here for the control of apoptosis in mammalian cell culture, the approach opens up novel 
perspectives in fundamental research and applications such as tissue engineering.
A common approach to study the function of a protein of interest in mammalian cells is to artificially manipulate 
its expression level. This approach is versatile, as it can be applied to most types of proteins, and simple, since no 
regulation mechanisms of the endogenous proteins need to be known or modulated.
Initially, chemical-based switches were used to manipulate expression levels by controlling transcription. Such 
systems are based on transcriptional activators or repressors, which alter their conformation and hence their tar-
get DNA-binding affinity upon interaction with specific small molecules. However, chemical-based switches have 
many limitations such as potential toxic or off-target effects of the regulatory small molecule, its poor or unpredict-
able diffusion through tissues and the difficulty of removing it from cells, tissues or organisms1. Optogenetic sys-
tems have the potential to overcome these limitations, creating great interest in implementing them in animal cell 
systems in culture and in vivo2,3. As optogenetic systems offer almost unlimited spatiotemporal resolution, dozens 
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of switches have recently been implemented for the control of a wide range of intracellular processes including pro-
tein localization4, activity5 and stability6,7, multi-wavelength gene-expression control8–11 and organelle motility12.
Optogenetic switches that control cellular protein abundance have in the last years shown much relevance 
and utility in biological research2. Most systems developed to date are based on the light-regulated induction of 
gene expression, some of which are reversible by illumination8, therefore allowing high temporal and quantitative 
control. Systems to reduce protein levels are, however, not as established. Currently, only few systems are capa-
ble of down-regulating protein levels6,13. However, none of the existing systems actively represses transcription 
which would contribute to an efficient and quantitative reduction of protein levels. To address this limitation, 
we envisioned that an optogenetic system that actively represses promoter activity and simultaneously targets 
protein stability would result in superior reduction of cellular protein levels in terms of rate and quantitative 
control. For this purpose, we have developed a novel dual-controlled optogenetic system (‘Blue-OFF’) that com-
bines transcriptional repression with regulation of protein stability, upon illumination with a single wavelength. 
The Blue-OFF system consists of two blue light-responsive protein modules: a novel, light-responsive repres-
sor, KRAB-EL222, and the protein degradation module B-LID6,9. Both components utilize light-oxygen-voltage 
(LOV) domains, which react to blue light illumination using a flavin mononucleotide (FMN) as chromophore. 
Blue light illumination induces an adduct formation between FMN and a cysteine in the LOV domain, which 
triggers a conformational change in the protein, changing its effector function14,15.
EL222 is a photosensitive transcription factor from the bacterium Erythrobacter litoralis. This transcription 
factor consists of a light sensitive LOV domain and a helix-turn-helix (HTH) DNA-binding domain, which can 
mediate light-induced transcription activation. In the dark, the LOV domain binds the HTH domain, preclud-
ing dimerization of the transcription factor and therefore no specific binding to a cognate DNA-sequence takes 
place. Blue light illumination disrupts the inhibitory LOV-HTH interactions and allows EL222 to homodimerize 
and bind specifically to the DNA sequence (C120). This interaction spontaneously reverses in the dark render-
ing EL222 inactive (τ ~ 11 s at 37 °C)16–18. EL222 has already been adapted for light controllable transcriptional 
activation in mammalian cells by fusing it to a virus-derived transactivator domain9. We demonstrate for the first 
time its use as light-inducible transcriptional repressor by fusing it to the KRAB transrepressor domain to inhibit 
transcription from a constitutive promoter19.
The B-LID module incorporates the LOV2 domain from Avena sativa phototropin 1 (AsLOV2). Illumination 
of AsLOV2 leads to an unwinding of the C-terminal Jα helix that is bound to the LOV core domain in the dark6. 
This structural change reverses spontaneously in darkness (τ ~ 80 s at 22 °C)6. This mechanism can be exploited 
by integrating small peptide tags in the C-terminal Jα helix which then are structurally hidden in the dark and 
are only exposed upon illumination. For the development of the B-LID module, the peptide sequence RRRG 
was fused to the Jα helix of AsLOV2 leading to the light inducible proteasome-mediated degradation of a linked 
protein6,7,15.
We present the combination of both modules in a single optogenetic system, which allows accurate con-
trol of protein production simultaneously on transcriptional and post-translational levels (Fig. 1a). This com-
binatorial approach enables a stronger, faster and longer-lasting reduction of cellular protein levels compared 
to the single modules, demonstrating the effectiveness of integrating repression on a transcriptional as well as 
a post-translational level. As a proof of principle, we have demonstrated the functionality of Blue-OFF with the 
reporter protein firefly luciferase and the mouse protein Caveolin-1 (CAV1). We show here that the Blue-OFF 
repression system can efficiently reduce protein expression levels, in different mammalian cell lines. Moreover, we 
developed a mathematical model to describe the activity of the Blue-OFF system which can hence be used for the 
experimental design by guiding the choice of irradiation conditions for obtaining desired repression levels. In line 
with these results, we further showed the applicability of the system for the optogenetic control of programmed 
cell death in mammalian cells by combining a drug-controlled caspase with the Blue-OFF system.
We present the first optogenetic repression system based on multiple photoreceptor modules that combines 
active repression with the control of protein stability and establish its use in a synergistic system. Taken together, 
our data highlight the advantages and strengths of this novel tool to complement the optogenetic toolbox.
Results
Design of a high-performance repression system by combining optogenetic modules. The 
optogenetic repressor module KRAB-EL222 was constructed by fusing a repressive KRAB domain, derived 
from the human kox-1 gene19, and two nuclear localization signals (NLS) to the N-terminus of EL222. The 
KRAB-EL222 module was cloned into an SV40 promoter-driven mammalian expression vector (pKM565) 
(Fig. 1a). As a light-regulated protein degradation system, we chose the B-LID system6. The functionality of 
both modules was assayed using a firefly luciferase (FLuc) reporter (pMZ1203), constructed to combine tran-
scriptional and post-translational regulation (Fig. 1a): Transcriptional regulation was achieved by placing the 
FLuc under the control of a constitutive SV40 promoter followed by five copies of the EL222-binding sequence, 
(C120)5, for binding of KRAB-EL222. Protein stability control was provided by fusing the B-LID degradation 
module C-terminally to FLuc. We first characterized the functionality of each module independently. The B-LID 
system was tested by replacing the EL222-KRAB module with the E-KRAB (pWW43) variant that cannot bind to 
(C120)5. To test the KRAB-EL222 module independently, a reporter similar to pMZ1203 but lacking the RRRG 
degradation sequence (pMZ1210) was constructed. HEK-293T cells were transfected with the indicated plasmids 
in a 1:1 (w:w) ratio, incubated in the dark for 16 h, and illuminated for 8 h with 20 µmol m−2 s−1 of 460 nm light 
(Fig. 1b). Cells transfected with the two control plasmids showed no difference in luciferase expression between 
illuminated and non-illuminated cells (Fig. 1b, ‘Non-regulated’). Cells transfected with only the KRAB-EL222 
system showed a 50% repression in cells illuminated for 8 h, compared to those kept in the dark, demonstrating 
the functionality of this new photosensitive repressor. Additionally, we engineered and tested a set of variants of 
this module, none of which showed any better repressive behavior (Fig. S1). Cells transfected with only the B-LID 
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Figure 1. Design and validation of the Blue-OFF system. (a) Mode of function and constructs. Expression of 
the reporter protein FLuc-B-LID is placed under the control of a SV40 promoter followed by five copies of the 
EL222-binding sequence, (C120)5. The photosensitive transcription factor EL222 is fused to an inhibitory KRAB 
domain and to two nuclear localization sequences (NLS). In the dark, KRAB-EL222 cannot bind to (C120)5. 
Upon blue light illumination, KRAB-EL222 dimerizes and binds to (C120)5 sequence inhibiting transcription. 
FLuc is fused to a B-LID module: in the dark the degradation peptide (RRRG) is docked to the LOV domain 
and thus covered. Blue light illumination exposes the peptide and leads subsequently to proteasome-mediated 
protein degradation. (b) Validation of the combined transcriptional and post-translational regulation. HEK-
293T cells were transfected transiently with either no blue light-sensitive regulation module (Non-regulated: 
pWW43 + pMZ1210), single regulation modules (KRAB-EL222 only: pKM565 + pMZ1210; or FLuc-B-LID 
only: pWW43 + pMZ1203) or both modules together for the Blue-OFF system (pKM565 + pMZ1203). The 
cells were kept either in darkness for 24 h (black bars) or for 16 h in the dark conditions and then illuminated 
with 460 nm light for 8 h (blue bars). FLuc levels shown here are normalized to their dark control. (c) Constructs 
of the CAV1-Blue-OFF system. In darkness CAV1 accumulates whereas under blue light illumination active 
repression of transcription and degradation leads to a net decrease of CAV1 levels. CAV1 knock out (KO) 
primary embryonic fibroblast cells were transfected with KRAB-EL222 and CAV1-B-LID (pJB013 and pJB023, 
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system showed 46% of the expression in non-illuminated cells. The dual-regulated system exhibited stronger 
repression, with only ~10% of the control levels of protein remaining. The level of down-regulation achieved is 
even stronger than a pure multiplicative combination of the two single modules. This result is due to nonlineari-
ties in the system and shows a synergistic effect of the two optogenetic modules (Fig. 1b, ‘Blue-OFF’). To extend 
the applicability of the dual-controlled Blue-OFF repression system we investigated its ability to down-regu-
late proteins other than reporters, e.g. Caveolin-1 (CAV1). CAV1 is the major component of endocytic caveolae 
plasma membrane invaginations and plays a critical role in normal tissue architecture and tumor progression20,21. 
In order to test the system, we employed the Blue-OFF system for controlling CAV1 levels (Fig. 1c). The plasmids 
contained EGFP as reporter to monitor transfected cells. The system was transfected in CAV1 knock-out (KO) 
mouse embryonic fibroblasts (MEFs). Cells were illuminated for 16 h with 2 µmol m−2 s−1 of 460 nm. CAV1 
expression levels were evaluated using immunofluorescence microscopy (Figs 1c, S2). As expected, CAV1-KO 
cells transfected with Blue-OFF and kept in darkness showed high expression of CAV1, whereas after blue light 
illumination, CAV1 levels significantly decreased but not co-expressed EGFP signals.
Following these results, we set out to characterize the kinetics of repression, to gain a better insight into the 
contribution of transcriptional and posttranslational regulation on performance of the dual-regulated Blue-OFF 
system. Cells were incubated for 16 h in the dark followed by 0, 2, 4 or 8 h of illumination prior to the determi-
nation of luciferase activity (Fig. 1d). The non-regulated, blue light-insensitive control system showed ongoing 
protein accumulation unaffected by illumination (black line). In contrast, protein accumulation was halted by 
controlling only transcription using KRAB-EL222 (purple line). The repression of transcription first became 
apparent on the protein level 2 h after illumination, when no further increase, but a slow decrease of protein accu-
mulation was observed. The 2 h delay is likely the result of ongoing translation from already synthesized mRNA 
during this time. In contrast, posttranslational control via protein degradation with the B-LID system showed 
a stronger and more immediate effect than transcriptional regulation (red line). The dual-regulated Blue-OFF 
system integrated the rapid, but temporally limited degradation effect of the B-LID system, with a delayed but 
persistent repressive effect of KRAB-EL222 to achieve a faster, stronger and longer-lasting repression (blue line). 
Furthermore, in contrast to the systems using a single optogenetic module, only the dual-controlled system 
achieved an absolute decrease in cellular protein levels after starting illumination. Our data demonstrates that 
the combination of transcriptional and posttranslational regulation in the Blue-OFF system results in a superior, 
light-induced down-regulation of a protein of interest.
Reversibility and versatility of the dual-controlled optogenetic Blue-OFF system. A key advan-
tage of light as an inducer is its high temporal precision and the reversibility of its application to a given bio-
logical system22. To evaluate reversible control of protein expression, HEK-293T cells expressing the Blue-OFF 
system were kept in darkness for 12 h, followed by a cycle of 12 h blue light illumination and 12 h darkness. Blue 
light illumination resulted in a 90% reduction of the protein level reached in darkness. Another 12 h of darkness 
allowed the protein levels to recover, demonstrating that the Blue-OFF system can control protein expression in 
a reversible manner (Fig. 2a).
To validate versatility, the Blue-OFF system was implemented in different mammalian cell lines. To this 
end, we expressed the system transiently in human embryonic kidney cells (HEK-293T), human cervical can-
cer cells (HeLa), chinese hamster ovary cells (CHO-K1), mouse embryonic fibroblasts (NIH/3T3) and monkey 
fibroblast-like cells (COS-7). Cells were kept in darkness for 16 h, followed by 8 h of blue light illumination. Blue 
light illumination resulted in a 70% to 90% decrease of reporter protein expression among the various cell lines, 
suggesting a high versatility and cross-species applicability of the Blue-OFF system (Fig. 2b).
Development of a quantitative model to describe the activity of the Blue-OFF system. To fur-
ther characterize the Blue-OFF system and its contributing modules, we developed a mathematical model based 
on ordinary differential equations (ODE) describing the time evolution of the concentrations of the involved 
substances. The model is parameterized using quantitative data on the time course and on the response to light 
intensity.
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respectively). After transfection cells were illuminated with 2 µmol m−2 s−1 of 460 nm light for 16 h. After 
fixation and permeabilization, cells were stained with an anti-CAV1 antibody followed by an AlexaFluor546-
labelled secondary antibody and nuclei were counterstained with DAPI. Cells were imaged by confocal 
microscopy. (d) Kinetics of the blue light regulation systems. HEK-293T cells were transfected as before and 
incubated in darkness for 16 h. Cells were then illuminated for 0, 2, 4 and 8 h with blue light. FLuc levels were 
measured at the indicated time points and are represented normalized to the values obtained after 16 h darkness. 
In b and c, data are means of four independent replicates and error bars indicate standard deviation of the mean.
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The Blue-OFF system is based on the light-induced conformational change of two proteins. On the one 
hand, the FLuc-B-LID switch exists in two conformations: FLucoff and FLucon. FLucoff is the form present in the 
dark with an inactive B-LID domain which is translated from FLucmRNA and degrades at the rate kdeg,const. By 
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Figure 2. Reversibility and versatility of the Blue-OFF system. (a) HEK-293T cells were transfected with 
KRAB-EL222 (pKM565) and FLuc-B-LID (pMZ1203).and kept in darkness for 12 h followed by 12 h blue light 
illumination and again 12 h darkness. FLuc levels were measured every 2 h. (b) Blue-OFF characterization 
using different mammalian cell lines. The indicated cell lines were transfected with KRAB-EL222 and FLuc-
B-LID. Cells were kept in darkness for 16 h followed by 8 h of 460 nm blue light illumination. FLuc levels were 
determined at the final time point. To correct for different transfection efficiencies, the expression data were 
normalized to co-transfected constitutively expressed Renilla luciferase (RLuc). In a and b, data are means of 
four independent replicates and error bars indicate standard deviation of the mean.
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Figure 3. Quantitative characterization of the behavior of the Blue-OFF system to calibrate the mathematical 
model. The model was calibrated using kinetic (a) and intensity dose response data (b). For the dose response 
HEK-293T cells were transfected with the Blue-OFF system. The cells were kept in darkness for 16 h after 
transfection and subsequently illuminated for 8 h with 0, 2.5, 5, 10, 15 and 20 µmol m−2 s−1 of 460 nm light. 
Shown is the relative reporter expression on a logarithmic scale. The dots indicate the experimental data points 
and the solid lines show the model simulation for the optimal parameter set. The shaded error bands are 
estimated by using an error model assuming a log-normally distributed error.
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illumination with blue light with the intensity I(t), the protein changes its conformation to FLucon and is availa-
ble for degradation via the proteasome. The parameter Km,deg describes saturation of the proteasome-dependent 
protein-degradation machinery. On the other hand, the light-inducible transcriptional repressor EL222-KRAB 
is in an inactive form in the dark, KRABoff. Upon illumination with blue light the conformation is changed to 
KRABon, which represses the transcription of the FLucmRNA. The FLucmRNA is produced with the constitutive tran-
scription rate ktranscript in the absence of EL222-KRAB. A detailed derivation of the model equations can be found 
in the Supplementary Information.
The model was calibrated by using the measured kinetics (Figs 1d and 3a) and light intensity ‘dose’-response 
data (Fig. 3b). The parameters were estimated by maximizing the likelihood function. The resulting fit is shown 
in Fig. 3. The model can explain the measured data, including the high synergistic repression in the combined 
system. An analysis of the calibrated model suggests as reason the saturation in the process of the B-LID induced 
protein degradation. In cells transfected only with the B-LID system the FLuc degradation is saturated whereas 
for the combined system the FLuc concentration is lower therefore not reaching saturation in its degradation. 
To assess the uncertainties of the estimated parameters, we calculated the profile likelihood of each parameter23. 
The detailed fitting process, estimated parameter values and their 95% confidence intervals are shown in the 
Supplementary Information. The parameter estimation and the profile likelihood analysis were performed with 
the Data2Dynamics framework24.
Implementation of the mathematical model to predict experimental outcomes. Next, we aimed 
to control the level of repression in a predictable manner by adjusting the illumination time and intensity using 
the calibrated mathematical model to predict the performance and operating range of the system. Figure 4a shows 
the predicted expression level of FLuc for different light intensities and illumination times. This map helps iden-
tifying the illumination conditions needed to obtain a desired reporter expression level.
Several experimental conditions were selected (A-F in Fig. 4a) and the reporter protein levels were compared 
to the values predicted from the mathematical model to test the applicability of the model to achieve a desired 
expression level by choosing the illumination time and light intensity (Fig. 4b). The uncertainties of the estimated 
model parameters lead to an uncertainty of the model prediction. To quantify this uncertainty in terms of predic-
tion confidence intervals, we analyzed the prediction profiles likelihood25 (Fig. 4b, colored boxes). The predicted 
expression levels (colored boxes) and the experimentally obtained expression levels (individual blue stars) show 
a strong correlation. These results indicate the applicability and usefulness of the model to determine conditions 
for experimental setups to achieve specific repression levels. Moreover, this shows the highly tunable repression 
levels of the Blue-OFF system by varying light intensity or illumination time.
Controlling programmed cell death using the Blue-OFF system. Finally, we set out to implement 
the Blue-OFF system to achieve light control over apoptosis in mammalian cells. For this purpose, we customized 
the tamoxifen inducible apoptosis-inducing caspase protein (Casp8-ER(T2)), previously described by Cachat 
et al.26. Caspase 8 is predominantly present as an inactive monomer, but upon addition of 4-hydroxytamoxifen 
(4-OHT) the ER(T2) domain brings about dimerization and activation, triggering apoptosis27. We integrated this 
module into the Blue-OFF system for blue-light control of caspase8 stability (Casp8-ER(T2)-Blue-OFF) (Fig. 5a). 
log10(FLuc) [a.u.]
10 12 14 16 18 20
0
5
10
15
20
25
In
te
ns
ity
 [µ
m
ol
 m
-2
 s-
1 ]
-0.6
-0.4
-0.2
0
0.2
0.4
0.6
8 3/10 3/25 10/5 10/20 15/2 15/15
-0.8
-0.6
-0.4
-0.2
0
0.2
0.4
0.6
0.8
1
lo
g 1
0(F
Lu
c)
 [a
.u
.]
A B C D E F
6420
A
C
E
B
D
F
a b
Figure 4. Model-aided prediction of protein expression levels using the Blue-OFF system. (a) Simulated 
reporter expression for different light intensities and illumination times for characterizing the system. To 
validate if the model can be used to determine experimental conditions to obtain a desired protein level 
six combinations with different intensities and illumination durations were measured and compared to the 
model predictions (red circles). The colored filling in the red circles indicates the experimentally determined 
expression levels. (b) The means of four determinations for each combination are denoted with blue stars 
and the error bars are showing the standard error of the mean. The colored boxes show the 95% prediction 
confidence interval calculated by analyzing the prediction profile likelihood.
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HEK-293 cells transfected with Casp8-ER(T2) showed significant apoptosis upon induction with 4-OHT both in 
the dark or under blue light, whereas cells transfected with the Casp8-ER(T2)-Blue-OFF system were able to grow 
and form a monolayer under blue light (Fig. 5b).
Subsequently, a caspase 8 activity assay was performed in order to correlate the protective effect of the dual 
Blue-OFF system on cell survival with reduced activity of caspase 8. After addition of 4-OHT, a 7-fold increase 
in caspase 8 activity was observed (Fig. 5c) in cells transfected with the Casp8-ER(T2)-Blue-OFF system when 
kept in the dark compared to transfected cells without addition of 4-OHT. When illuminated with blue light a 
60% reduction in caspase 8 activity was observed (Fig. 5c), which is in line with the reduced cell death (Fig. 5b). 
As expected, blue light had no effect on caspase 8 activity in 4-OHT induced control cells transfected with 
Casp8-ER(T2). These results indicate that the Blue-OFF system can efficiently be used for the optogenetic control 
of programmed cell death in mammalian cells and opens up the possibility for the selective induction of apoptosis 
in specific cells by local illumination that is unachievable with diffusible drugs.
Discussion
The recent development of light-regulated synthetic molecular switches has considerably contributed to a better 
insight into the functions and characteristics of proteins in regulatory networks (www.optobase.org)28. A com-
mon function of these switches is to upregulate protein abundance in biological systems, their subcellular locali-
zation or their activity29. While there is a broad set of optogenetic tools available to upregulate protein expression, 
only few systems are available to reduce protein levels. Despite successful results in various experimental designs, 
these down-regulation approaches are not as efficient in terms of absolute reduction of protein levels.
To improve the efficiency of transgene expression control, transcription-translation networks have been devel-
oped. These dual approaches enable tighter control of protein expression, however until recently mainly relied on 
chemical switches13,30–33.
For this purpose, we engineered a dual-controlled optogenetic switch, Blue-OFF, that confers rapid and 
sustained, blue light sensitive down-regulation of protein expression levels by simultaneously targeting gene 
repression and protein stability. The novel blue light-responsive repressor KRAB-EL222 was combined with the 
protein degradation module B-LID constituting a system that can be regulated upon illumination with a single 
wavelength.
By combining both levels of regulation the Blue-OFF system outperforms existing down-regulation systems.
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Figure 5. Application of the Blue-OFF system for the control of programmed cell death. (a) Constructs of 
the Casp8-ER(T2)-Blue-OFF system. (b,c) Optogenetic control of programmed cell death in HEK-293 cells 
transfected with the Casp8-ER(T2)-Blue-OFF system. (b) HEK-293 cells transfected with the Casp8-ER(T2) or 
the Casp8-ER(T2)-Blue-OFF systems form a uniform monolayer under blue light exposure or in darkness in 
the absence of 4-OHT. Induction of caspase 8 activity upon 4-OHT addition leads to cell death in darkness (for 
Casp8-ER(T2) and Casp8-ER(T2)-Blue-OFF) and under blue light exposure for Casp8-ER(T2), whereas cells 
transfected with the Casp8-ER(T2)-Blue-OFF system show a higher survival rate under blue-light conditions, 
thus building a uniform cell monolayer. (c) Quantification of caspase8 activity. The figure shows the caspase 
8 activity of HEK-293 cells transfected with the Casp8-ER(T2) system (left) or the light-regulated Casp8-
ER(T2)-Blue-OFF system (right), in the presence and absence of 4-OHT and blue light. Values are mean of 
three independent experiments and error bars indicate standard deviation of the mean. Statistical significance 
between the tested conditions for each system is indicated with uppercase letters above each bar, where “A” 
significantly differs from “B”, “B” from “C”. One-way analysis of variance (ANOVA), P < 0.005.
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Efficient down-regulation of protein expression is instrumental in answering many biological questions. 
Biological systems are highly dynamic, thus, reversibility is a key feature of synthetic molecular switches to better 
understand biological processes. Therefore, light emerges as optimal superior inducer, since it can be applied and 
withdrawn from biological systems in a fully reversible manner. Here, we showed how protein down-regulation 
by the Blue-OFF system is fully reversible. Moreover, we were able to validate the functionality of the system in 
different cell types, which proves its broad applicability.
To quantitatively understand the underlying processes in light-inducible gene repression and protein degrada-
tion, we developed a quantitative mathematical model that was parameterized with the experimental data. Using 
this model, it is possible to set the experimental parameters (light intensity and illumination regime) for tuning 
the Blue-OFF for desired applications. Blue-OFF can, furthermore, easily be combined with other systems by 
placing the target site of the repressor modules KRAB-EL222 behind any endogenous or synthetic promoter and 
by fusing B-LID to any protein of interest. The Blue-OFF was successfully applied for the control of programmed 
cell death which opens up novel perspectives for creating cellular patterns with high spatiotemporal resolution. 
In the frame of the current development of strategies for engineering multicellular systems, the Blue-OFF system 
could contribute to synthetic tissue engineering approaches and the generation of complex 3D structures.
In conclusion, we have shown that the novel Blue-OFF optogenetic approach for controlling protein levels, 
acting simultaneously on transcriptional and post-translational levels, leads to a fast and strong reduction of the 
net level of the protein of interest. In addition, a model-based quantitative characterization of the system kinetics 
enables the rational adjustment of parameters to achieve desired repression levels. The strong repressive effect 
together with the predictive properties of the system constitute a powerful and versatile tool. For the future, we 
envision that this system will be used to answer fundamental biological questions and boost applications such as 
in tissue engineering.
Methods
Plasmids. The design and the construction of the expression vectors are described in Tables S2, S3.
Cell culture and transfections. Chinese hamster ovary cells (CHO-K1) were cultivated in HTS medium 
(Cell Culture Technologies) supplemented with 10% tetracycline-free fetal calf serum (FCS, PAN, cat. no.: P30–
3602, lot no.: P101003TC), 2 mM L-glutamine (Sigma), 100 U mL−1 penicillin and 0.1 mg mL−1 streptomycin 
(PAN). Mouse embryonic fibroblast cells (NIH/3T3), human embryonic kidney cells (HEK-293T), African green 
monkey fibroblast-like cells (COS-7), and human epithelioid cervix carcinoma cells (HeLa) were maintained 
in Dulbecco’s modified Eagle’s medium (DMEM, PAN, cat. no. P04–03550) supplemented with 10% FCS (FCS, 
PAN, cat. no.: P30-3306, lot no.: P140204), 100 U mL−1 penicillin and 0.1 mg mL−1 streptomycin (PAN) at 37 °C 
with 5% CO2. For transfection, 30,000-75,000 cells per well of a 24-well plate were transfected using polyethyl-
enimine (PEI, linear, MW: 25 kDa, Polyscience) as describes elsewhere34. Unless otherwise indicated, cells were 
transfected with constructs comprising the light responsive repressor KRAB-EL222 (pKM565), FLuc-B-LID 
(pMZ1203) and as a control CMV driven Renilla Luciferase (RLuc) at a ratio of 20:20:1 (w:w:w), respectively.
Immortalized mouse embryonic fibroblasts (MEFs) were obtained from Caveolin 1-deficient mice (B6.
Cg-CAV1tm1mls/J35). Immortalization was induced by the simian virus 40 large T antigen (SV40-Tag). Cells 
were cultured in DMEM (1×) + GlutMAXTM (Gibco, cat. no.: 61965–026) supplemented with 10% fetal bovine 
serum (Gibco, cat. no.: 10270–106, lot no.: 42F9251K), 50 U mL−1 penicillin and 0.05 mg mL−1 streptomycin 
(Gibco, cat. no.: 15140–122) and 50 µM β-mercaptoethanol (Sigma). Transfections for MEFs were done using 
TransitX2 (Mirus, cat. no.: MIR6000). 70.000 cells were seeded in 12-well plates and transfected using 1 µg of 
DNA/3 µl TransitX2.
Human embryonic kidney (HEK-293) cells were maintained in DMEM (Gibco, cat. no.: 41966) supplemented 
with 10% fetal bovine serum (Biosera, cat. no.: FB1090/500, lot no.: 013BS145) in a humidified incubator at 
37 °C and 5% CO2. HEK-293 cells were harvested by trypsinization 24 h prior to transfection, and seeded at 
a density of 80.000 cells in 500 µl of complete medium per well on 24 well plates. Cells were transfected with 
lipofectamine 3000 (Invitrogen, cat. no.: L3000–008). Unless otherwise indicated cells were transfected with 
pTREX-BLID-mCherry-2A-myrcasp8-ER(T2), pKM565 or pTREX-myrCasp8-ER(T2)-IRES-mCherry. After 
24 hours, the medium was replaced by fresh growth medium.
Light induction. Cells were kept in darkness or were illuminated with 460 nm light for the indicated time 
periods at a photon flux density of 20 µmol m−2 s−1, unless indicated otherwise. Illumination was performed 
with light boxes similar to36 with LED panels emitting at 460 nm (LED Engin, cat. no.: LZ1-10B202-0000). All 
cell-handling involving the blue-light inducible systems was done under 628 nm light which does not affect the 
light-sensitive systems described here.
Reporter gene assay. Luciferase expression was quantified by lysing cells on ice with 250 µl luciferase lysis 
buffer (25 mM Tris/HCl, pH 7.8, 1% Triton X-100, 15 mM MgSO4, 4 mM ethylene glycol tetraacetic acid (EGTA), 
1 mM DTT) per well on ice for 15 min. 80 µl lysate was transferred to Costar® 96-well flat-bottom white plates 
(Corning Incorporated, Germany). Firefly and Renilla luciferase luminescence was directly monitored using 
either a Synergy 4 multimode microplate reader (BioTek Instruments Inc., Winooski, VT) or an Infinite 200Pro 
microplate reader (Tecan, Switzerland) after addition of 20 μl of either firefly luciferase substrate (20 mM Tricine, 
2.67 mM MgSO4, 0.1 mM EDTA, 33.3 mM DTT, 0.52 mM ATP, 0.27 mM Acetyl-CoA, 5 mM NaOH, 264 µM 
MgCO3, 0.47 mM luciferin) or Renilla luciferase substrate (472 μM coelenterazine stock solution in methanol; 
diluted directly before use, 1:15 in PBS).
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Immunofluorescence microscopy. Cells were fixed in 4% paraformaldehyde for 15 min at room tem-
perature and washed three times in PBS, permeabilized in 0.5% Triton X-100 for 15 min at room temperature, 
rewashed in PBS and blocked in PBS with1% BSA for 30 min at room temperature. Subsequently, cells were 
incubated overnight at 4 °C with the primary anti-Caveolin-1 antibody (1:200 in blocking buffer; BD biosciences, 
cat. no.: 610060). Following washing with blocking buffer, cells were incubated with AlexaFluor546-conjugated 
secondary goat anti-rabbit antibody (1:200 in blocking solution; Invitrogen cat. no.: A11035) for 2 h at 
37 °C, rewashed and mounted on microscopy slides in ProLong Gold Antifade Mountant containing DAPI 
(ThermoFisher; cat. no.: P36931).
Cells were imaged with Nikon Instruments Eclipse Ni-E with a C2+ confocal laser scanner (100× Plan Apo 
λ oil immersion objective, NA = 1.45). DAPI, GFP and AlexaFluor546 were visualized using excitation lasers of 
405, 488 and 561 nm and emission filters of 445/50, 525/50 and 660 nm LP, respectively. Image acquisition was 
performed with NIS-Elements AR (Nikon Instruments, version 4.20). Cells were defined as regions of interest 
according to their EGFP expression. Subsequently, mean fluorescence intensities of GFP and CAV1 signals were 
measured. Analyses were performed with Fiji37.
Induction of apoptosis. Transfected HEK-293T cells were kept in the dark or were exposed to blue light 5 h 
before treatment with 1 µM 4-Hydroxytamoxifen (4-OHT, Sigma, cat. no.: H7904) to induce apoptosis. Images 
were acquired 48 hours after induction with 4-OHT using a Zeiss Axio Observer D1 inverted microscope with 
AxioCam MRm and a 20x objective.
Caspase8 activity assay. Transfected HEK-293T cells were kept in the dark or were exposed to blue light 
3 h before treatment with 1 µM 4-OHT. All cells were detached 3 hours after induction with 4-OHT and centri-
fuged at 500 g for 10 min. The supernatant was discarded and cells washed with PBS. After centrifugation, cell 
pellet was resuspended in cold Lysis Buffer (10 mM Tris-Cl at pH 7.4, 100 mM NaCl, 2.5 mM MgCl2, 0.5% NP-40, 
0.5% Triton X-100) and incubated for 10 min. The cell lysate was centrifuged at 10,000 × g for 3 min. In order to 
quantify the Caspase8 activity, 80 µl of the resulting supernatant were mixed with 80 µl of the Caspase-Glo® 8 
reagent (Promega) in 96 well flat bottom white microplates (LumitracTM 200, Greiner) for 20 min. Luminescence 
intensity was measured in RLU (relative luminescence units) with the BMG FLUOstar OPTIMA Microplate 
Reader.
Statistical analysis. One-way ANOVA with Tukey Pairwise Comparisons were performed using Minitab 
17 Statistical Software (2010). Unpaired t-tests were performed using GraphPad Prism 6. Outliers for statistical 
analysis of CAV1 intensities were determined and excluded as described in38.
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